CIPRIANI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 6.494
EU - Europa 5.997
AS - Asia 2.389
SA - Sud America 106
OC - Oceania 15
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 15.025
Nazione #
US - Stati Uniti d'America 6.454
GB - Regno Unito 2.282
CN - Cina 1.314
SG - Singapore 858
IT - Italia 778
FR - Francia 568
RU - Federazione Russa 537
FI - Finlandia 451
DE - Germania 391
IE - Irlanda 385
SE - Svezia 331
UA - Ucraina 148
BR - Brasile 91
VN - Vietnam 71
TR - Turchia 34
NL - Olanda 30
JP - Giappone 28
CA - Canada 27
IL - Israele 19
RO - Romania 17
BE - Belgio 16
AU - Australia 15
HK - Hong Kong 11
ID - Indonesia 11
AT - Austria 10
MX - Messico 10
CH - Svizzera 9
EU - Europa 9
ES - Italia 7
PL - Polonia 6
HU - Ungheria 5
AZ - Azerbaigian 4
EG - Egitto 4
GR - Grecia 4
IN - India 4
IR - Iran 4
KR - Corea 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
BG - Bulgaria 3
BY - Bielorussia 3
PH - Filippine 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AM - Armenia 2
BD - Bangladesh 2
CL - Cile 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
KE - Kenya 2
KH - Cambogia 2
LT - Lituania 2
MA - Marocco 2
PE - Perù 2
RS - Serbia 2
SC - Seychelles 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 15.025
Città #
Southend 2.103
Jacksonville 1.297
Woodbridge 967
Chandler 841
Singapore 676
Ann Arbor 580
Houston 549
Dublin 385
Wilmington 222
Lawrence 216
Princeton 216
Beijing 208
Ashburn 185
Verona 153
Nanjing 128
Jinan 110
New York 107
Shenyang 103
Milan 91
Hebei 73
Dong Ket 56
Helsinki 51
Sindelfingen 47
Changsha 45
Nanchang 45
Tianjin 45
Haikou 40
Rome 40
Ningbo 35
Hangzhou 34
Boardman 33
Washington 32
Norwalk 31
Dearborn 30
Redwood City 30
Guangzhou 29
Taiyuan 29
Zhengzhou 28
Jiaxing 25
Taizhou 24
Moscow 21
Bologna 20
Lancaster 20
San Francisco 18
Toronto 18
Tokyo 17
Santa Clara 16
Florence 15
Fuzhou 15
Los Angeles 15
Brussels 14
Düsseldorf 13
Falls Church 13
Lanzhou 12
Hong Kong 11
London 11
Shanghai 11
Munich 10
Fairfield 9
Jakarta 9
Naples 9
Amsterdam 8
Cagliari 8
Mexico City 8
Seattle 8
Timisoara 8
Dongguan 7
Groningen 7
Kent 7
Berlin 6
Canberra 6
Isorella 6
Melbourne 6
São Paulo 6
Zurich 6
Auburn Hills 5
Dallas 5
Genoa 5
Stockholm 5
Trento 5
Vienna 5
Baku 4
Brampton 4
Brasília 4
Bratislava 4
Brescia 4
Contagem 4
Frankfurt am Main 4
Manchester 4
Padova 4
Parma 4
Redmond 4
Rochester 4
Saint Petersburg 4
San Diego 4
Seoul 4
Stuttgart 4
Tel Aviv 4
Turin 4
Villafranca Tirrena 4
Totale 10.439
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 418
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 321
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 168
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 135
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 127
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 123
Assessing risk of bias in randomized controlled trials 123
What is a run-in phase? 120
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 119
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 115
Are all antidepressants really the same? The case of fluoxetine: a systematic review 110
What is a systematic review? 110
Associazione tra TCA e SSRI nella depressione resistente 106
Imputing missing standard deviations in meta-analyses can provide accurate results 106
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 104
What is a forest plot? 102
Antidepressants and benzodiazepines for panic disorder in adults 102
Agomelatine and the brave old world of narrative-based medicine 100
Allocation concealment and blinding in clinical trials 99
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 99
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 96
What is a risk ratio? 96
Randomized trials published in Chinese or Western journals: comparative empirical analysis 95
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 95
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 94
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 94
Citalopram versus other anti-depressive agents for depression 94
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 94
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 93
Sertraline versus other antidepressive agents for depression 93
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 93
Seven criteria for improving effectiveness trials in psychiatry 92
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 92
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 92
Antidepressive Monotherapie 91
Depressive disorders 91
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 91
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 91
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 89
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 88
Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants 87
Conventional vs. atypical antipsychotic medications [Letter] 86
Citalopram versus other anti-depressive agents for depression 86
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 86
Azapirones versus placebo for panic disorder in adults 86
Duloxetine versus other anti-depressive agents for depression 85
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 85
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 83
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 82
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 82
Paroxetine versus other anti-depressive agents for depression 82
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 81
Implementation of treatment guidelines for specialist mental health care 81
Commentary on: Analysis and reporting of factorial trials: a systematic review (McAlister et al., JAMA) 80
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 80
Citalopram versus other anti-depressive agents for depression. 80
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 79
What is a clinical trial protocol? 79
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 79
Benzodiazepines and risk of dementia: true association or reverse causation? 79
Implementation of treatment guidelines for specialist mental health care 79
Fluoxetine versus other types of pharmacotherapy for depression (Protocol for a Cochrane Review) 78
Mirtazapine versus other antidepressive agents for depression 78
"Wish bias" in antidepressant drug trials? 77
Fluoxetine versus other types of pharmacotherapy for depression (Review) 77
Understanding and using systematic literature reviews 76
Suicide, depression, and antidepressants. Patients and clinicians need to balance benefits and harms 75
Do selective serotonin reuptake inhibitors cause suicide? Authors' reply to Raven 75
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 75
Risk of suicidal behaviour in adults taking antidepressants 75
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 75
What is a multiple treatments meta-analysis? 75
What is a factorial trial? 74
Inglobare la ricerca nella pratica clinica quotidiana 73
Outcome reporting bias in clinical trials 73
What is an intention to treat analysis? 73
Antidepressants for Bipolar Disorder 73
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 73
Imputing response rates from means and standard deviations in meta-analyses 72
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 72
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 72
Review: Short-term benefit of escitalopram versus citalopram for depression uncertain, but big difference in French health insurance costs. 72
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 72
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials 71
Validity of the impact factor of journals as a measure of randomised controlled trial quality 71
Why internal and external validity of experimental studies are relevant for clinical practice? 71
Olanzapine in long-term treatment for bipolar disorder. 71
Implementation of treatment guidelines for specialist mental health care 71
Haloperidol alone or in combination for acute mania 70
What is an individual patient data meta-analysis? 69
Pharmacological treatment for unipolar psychotic depression 69
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 69
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis 69
Levels of evidence: can quality of systematic reviews be quantified? 68
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 68
Novel melatonin-based treatments for major depression 67
Sertraline versus other antidepressive agents for depression 67
International dose differences in fluoxetine clinical trials conducted in patients with depression 66
Explanatory and pragmatic trials 66
Does the addiction of a second antipsychotic drug improve clozapine treatment? 66
Totale 9.192
Categoria #
all - tutte 53.626
article - articoli 50.141
book - libri 246
conference - conferenze 0
curatela - curatele 0
other - altro 1.525
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.714
Totale 107.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020938 0 0 0 0 0 0 258 170 60 202 73 175
2020/20211.547 91 310 45 134 226 192 18 147 127 23 137 97
2021/20221.254 72 282 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20251.755 285 251 171 554 177 137 180 0 0 0 0 0
Totale 15.153